Search By:
Products
Injury
Topic
Company
Industry
Advance PCS might have engaged in anti-competitive behavior which harmed retail pharmacists.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topics
- Over Charge
- Price Fixing
- Anti-Competitive Behavior
- Overcharging for Drug
Product or Service
- Pharmacists
Injury Type
- Monetary Loss
Investigation Details
This is an ongoing investigation and pending class action against Advance PCS, which is a Prescription Benefit Manager acting as a purchasing agent for its plan sponsors.
This class action antitrust lawsuit alleges the existence of a horizontal agreement among competitors having the effect of restraining trade in the drug dispensing industry. The class action lawsuit alleges that the plan sponsors, through Advance PCS, eliminate competition for dispensing services, thereby reducing the reimbursement rates paid to retail pharmacists.
The claim also alleges that Advance PCS uses its market power to create artificial vertical advantages for its own mail order pharmacy business.
The suit seeks relief on behalf of retail pharmacists harmed by the alleged conspiracy.
This class action antitrust lawsuit alleges the existence of a horizontal agreement among competitors having the effect of restraining trade in the drug dispensing industry. The class action lawsuit alleges that the plan sponsors, through Advance PCS, eliminate competition for dispensing services, thereby reducing the reimbursement rates paid to retail pharmacists.
The claim also alleges that Advance PCS uses its market power to create artificial vertical advantages for its own mail order pharmacy business.
The suit seeks relief on behalf of retail pharmacists harmed by the alleged conspiracy.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| AdvancePCS Inc. | AdvancePCS Inc. was a large prescription benefit plan administrator. Caremark Rx Inc. acquired AdvancePCS Inc. in 2004. In 2008, Caremark RX merged with CVS to create CVS Caremark (NYSE: CVS). |